참고문헌
- Bolton-Maggs PH. Idiopathic thrombocytopenic purpura. Arch Dis Child 2000;83:220-2 https://doi.org/10.1136/adc.83.3.220
- Cines DB, Blanchette VS. Immune thrombocytopenic purpura. N Engl J Med 2002;346:995-1008 https://doi.org/10.1056/NEJMra010501
- Bolton-Maggs P. Severe bleeding in idiopathic thrombocytopenic purpura. J Pediatr Hematol Oncol 2003;25(Suppl 1): S47-51 https://doi.org/10.1097/00043426-200312001-00011
- Kuhne T, Buchanan GR, Zimmerman S, Michaels LA, Kohan R, Berchtold W, et al. A prospective comparative study of 2540 infants and children with newly diagnosed idiopathic thrombocytopenic purpuratl (ITP) from the Intercontinental Childhood ITP Study Group. J Pediatr 2003;143: 605-8 https://doi.org/10.1067/S0022-3476(03)00535-3
- Schiavotto C, Ruggeri M, Rodeghiero F. Adverse reactions after high-dose intravenous immunoglobulin: incidence in 83 patients treated for idiopathic thrombocytopenic purpura (ITP) and review of the literature. Haematologica 1993;78: 35-40
- Orbach H, Katz U, Sherer Y, Shoenfeld Y. Intravenous immunoglobulin: adverse effects and safe administration. Clin Rev Allergy Immunol 2005;29:173-84 https://doi.org/10.1385/CRIAI:29:3:173
- Berkovitch M, Dolinski G, Tauber T, Aladjem M, Kaplinsky C. Neutropenia as a complication of intravenous immunoglobulin(IVIG) therapy in children with immune thrombocytopenic purpura: common and non-alarming. Int J Immunopharmacol 1999;21:411-5 https://doi.org/10.1016/S0192-0561(99)00020-X
- Niebanck AE, Kwiatkowski JL, Raffini LJ. Neutropenia following IVIG therapy in pediatric patients with immunemediated thrombocytopenia. J Pediatr Hematol Oncol 2005; 27:145-7 https://doi.org/10.1097/01.mph.0000155871.26380.84
- Sugita K, Eguchi M. Suppressive effect of intravenous immunoglobulin on peripheral blood neutrophil count in patients with idiopathic thrombocytopenic purpura. J Pediatr Hematol Oncol 2005;27:7-10 https://doi.org/10.1097/01.mph.0000149239.68396.72
- Park JA, Park SS, Lim YT. Neutropenia following IVIG treatment in children with idiopathic thrombocytopenic purpura. In: Program & Abstract, the 56th Annual Fall Meeting of the Korean Pediatric Society; 2006. p. 113
- Treutiger I, Rajantie J, Zeller B, Henter JI, Elinder G, Rosthoj S. Does treatment of newly diagnosed idiopathic thrombocytopenic purpura reduce morbidity? Arch Dis Child 2007;92:704 -7 https://doi.org/10.1136/adc.2006.098442
- Watts RG. Idiopathic thrombocytopenic purpura: a 10-year natural history study at the Childrens Hospital of Alabama. Clin Pediatr(Phila) 2004;43:691-702 https://doi.org/10.1177/000992280404300802
- Tarantino MD, Madden RM, Fennewald DL, Patel CC, Bertolone SJ. Treatment of childhood acute immune thrombocytopenic purpura with anti-D immune globulin or pooled immune globulin. J Pediatr 1999;134:21-6 https://doi.org/10.1016/S0022-3476(99)70367-7
- Tarantino MD, Young G, Bertolone SJ, Kalinyak KA, Shafer FE, Kulkarni R, et al. Single dose of anti-D immune globulin at 75 microg/kg is as effective as intravenous immune globulin at rapidly raising the platelet count in newly diag nosed immune thrombocytopenic purpura in children. J Pediatr 2006;148:489-94 https://doi.org/10.1016/j.jpeds.2005.11.019
- Imbach P, Barandun S, d' Apuzzo V, Baumgartner C, Hirt A, Morell A, et al. High-dose intravenous gammaglobulin for idiopathic thrombocytopenic purpura in childhood. Lancet 1981;1:1228-31
- Nugent DJ. Immune thrombocytopenic purpura of childhood. Hematology Am Soc Hematol Educ Program 2006:97-103
- Blanchette V, Carcao M. Intravenous immunoglobulin G and anti-D as therapeutic interventions in immune thrombocytopenic purpura. Transfus Sci 1998;19:279-88 https://doi.org/10.1016/S0955-3886(98)00042-3
- Beck CE, Nathan PC, Parkin PC, Blanchette VS, Macarthur C. Corticosteroids versus intravenous immune globulin for the treatment of acute immune thrombocytopenic purpura in children: a systematic review and meta-analysis of randomized controlled trials. J Pediatr 2005;147:521-7 https://doi.org/10.1016/j.jpeds.2005.04.032
- Tam DA, Morton LD, Stroncek DF, Leshner RT. Neutropenia in a patient receiving intravenous immune globulin. J Neuroimmunol 1996;64:175-8 https://doi.org/10.1016/0165-5728(95)00167-0
- Altznauer F, von Gunten S, Spath P, Simon HU Concurrent presence of agonistic and antagonistic anti-CD95 autoantibodies in intravenous Ig preparations. J Allergy Clin Immunol 2003;112:1185-90 https://doi.org/10.1016/j.jaci.2003.09.045
- Tsujimoto H, Takeshita S, Nakatani K, Kawamura Y, Tokutomi T, Sekine I. Intravenous immunoglobulin therapy induces neutrophil apoptosis in Kawasaki disease. Clin Immunol 2002;103:161-8 https://doi.org/10.1006/clim.2002.5209
- Teeling JL, De Groot ER, Eerenberg AJ, Bleeker WK, Van Mierlo G, Aarden LA, et al. Human intravenous irnmuno globulin(IVIG) preparations degranulate human neutrophils in vitro. Clin Exp Immunol 1998;114:264-70 https://doi.org/10.1046/j.1365-2249.1998.00697.x
- Lee JH, Lee KS. Efficacy of very low-dose(200 mg/kg /d) with short-term intravenous immunoglobulin G therapy according to individual response of acute immune thrombocytopenic purpura in childhood. Clin Pediatr Hematol Oncol 2006;13:143-9
- Benesch M, Kerbl R, Lackner H, Berghold A, Schwinger W, Triebl-Roth K, et al. Low-dose versus high-dose immunoglobulin for primary treatment of acute immune thrombocytopenic purpura in children: results of a prospective, randomized single-center trial. J Pediatr Hematol Oncol 2003;25:797 -800 https://doi.org/10.1097/00043426-200310000-00011